» Authors » Jens M Debacker

Jens M Debacker

Explore the profile of Jens M Debacker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 50
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Maris L, Goker M, Debacker J, De Man K, Van den Broeck B, Van Dorpe J, et al.
EJNMMI Phys . 2024 Oct; 11(1):85. PMID: 39400788
Background: As the spatial resolution of positron emission tomography (PET) scanners improves, understanding of radiotracer distributions in tissues at high resolutions is important. Hence, we propose a method for co-registration...
2.
Zeven K, Lauwers Y, De Mey L, Debacker J, De Pauw T, De Groof T, et al.
Immunother Adv . 2024 Sep; 4(1):ltae006. PMID: 39281708
The evolving landscape of cancer immunotherapy has revolutionized cancer treatment. However, the dynamic tumor microenvironment has led to variable clinical outcomes, indicating a need for predictive biomarkers. Noninvasive nuclear imaging,...
3.
Van den Broeck B, Debacker J, Bauters W, Creytens D, Ferdinande L, Huvenne W, et al.
EJNMMI Res . 2024 Sep; 14(1):82. PMID: 39264376
Background: Patients diagnosed with radioiodine refractory (RAI-R) thyroid carcinoma (TC) have a significantly worse prognosis than patients with radiosensitive TC. These refractory malignancies are often dedifferentiated, hindering the effectiveness of...
4.
Vermassen T, De Keukeleire S, Saerens M, Heerwegh S, Debacker J, Huvenne W, et al.
Eur Arch Otorhinolaryngol . 2024 Jan; 281(6):2993-3004. PMID: 38228884
Purpose: Intestinal-type adenocarcinoma (ITAC) is a rare sinonasal malignancy. Curative treatment requires multidisciplinary approach, with surgical options consist of the endonasal endoscopic approach (EEA) and external surgery (EXTS). Here, we...
5.
do Valle N, Janssen S, Stroet M, Pollenus S, Van den Block S, Devoogdt N, et al.
Front Pharmacol . 2023 Oct; 14:1266288. PMID: 37781693
Surgical resection is one of the main treatment options for several types of cancer, the desired outcome being complete removal of the primary tumor and its local metastases. Any malignant...
6.
De Pauw T, De Mey L, Debacker J, Raes G, Van Ginderachter J, De Groof T, et al.
Expert Opin Investig Drugs . 2023 Aug; 32(8):705-721. PMID: 37638538
Introduction: Monoclonal antibodies have revolutionized personalized medicine for cancer in recent decades. Despite their broad application in oncology, their large size and complexity may interfere with successful tumor targeting for...
7.
Debacker J, Maris L, Cordier F, Creytens D, Deron P, Descamps B, et al.
Eur J Nucl Med Mol Imaging . 2023 Mar; 50(7):2127-2139. PMID: 36854863
Purpose: Recent technical advancements in PET imaging have improved sensitivity and spatial resolution. Consequently, clinical nuclear medicine will be confronted with PET images on a previously unfamiliar resolution. To better...
8.
Debacker J, Schelfhout V, Brochez L, Creytens D, DAsseler Y, Deron P, et al.
J Clin Med . 2021 Aug; 10(16). PMID: 34442033
The surgical treatment of head and neck malignancies relies on the complete removal of tumoral tissue, while inadequate margins necessitate the use of adjuvant therapy. However, most positive margins are...
9.
Debacker J, Gondry O, Lahoutte T, Keyaerts M, Huvenne W
Cancers (Basel) . 2021 Jul; 13(14). PMID: 34298638
An increased presence of CD206-expressing tumor associated macrophages in solid cancers was proposed to be associated with worse outcomes in multiple types of malignancies, but contradictory results are published. We...
10.
Deklerck A, Debacker J, Keppler H, Dhooge I
Clin Otolaryngol . 2020 Jun; 45(5):775-787. PMID: 32490603
Background: The origin of tinnitus has been attributed to a peripheral auditory lesion, inducing bottom-up changes and resulting in the perception of a "phantom sound." However, non-auditory factors can co-exist...